Qi-Zhi-Wei-Tong granules alleviates chronic non-atrophic gastritis in mice by altering the gut microbiota and bile acid metabolism

被引:4
|
作者
Chen, Man [1 ]
Li, Ying [1 ]
Li, Lan [1 ]
Ma, Qingyu [2 ]
Zhou, Xuan [2 ]
Ding, Fengmin [1 ]
Mo, Xiaowei [2 ]
Zhu, Wenjun [2 ]
Bian, Qinglai [1 ]
Zou, Xiaojuan [1 ]
Xue, Feifei [2 ]
Yan, Li [2 ]
Li, Xiaojuan [2 ]
Chen, Jiaxu [1 ,2 ]
机构
[1] Hubei Univ Chinese Med, Coll Basic Med, Wuhan 430065, Hubei, Peoples R China
[2] Jinan Univ, Guangzhou Key Lab Formula Pattern Tradit Chinese M, Formula Pattern Res Ctr, Sch Tradit Chinese Med, Guangzhou 510632, Peoples R China
基金
中国国家自然科学基金;
关键词
Qi-zhi-wei-tong granule; Chronic restraint stress combined with iodoacetamide; Chronic non-atrophic gastritis; Gut microbiota; Bile acid metabolism; ANGELICA-SINENSIS; RAT MODEL; DEPRESSION; LICORICE; MOTILITY;
D O I
10.1016/j.jep.2023.117304
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: In traditional Chinese medicine, Qi-zhi-wei-tong granule (QZWT) significantly reduced the major gastrointestinal and psychological symptoms of functional dyspepsia. Aim of the study: We aimed to explore the therapeutic effect of QZWT treated chronic non-atrophic gastritis (CNAG) and to elucidate its potential mechanism. Materials and methods: The composition of QZWT was analysed by UPLC-Q/TOF-MS. The CNAG mice model was established by chronic restraint stress (CRS) in combination with iodoacetamide (IAA). Morphological staining was utilized to reveal the impact of QZWT on stomach and gut integrity. RT-qPCR and ELISA were used to measure proinflammatory cytokines in the stomach, colon tissues and serum of CNAG mice. Next-generation sequencing of 16 S rDNA was applied to analyse the gut microbiota community of faecal samples. Finally, we investigated the faecal bile acid composition using GC-MS. Results: Twenty-one of the compounds from QZWT were successfully identified by UPLC-Q/TOF-MS analysis. QZWT enhanced gastric and intestinal integrity and suppressed inflammatory responses in CNAG mice. Moreover, QZWT treatment reshaped the gut microbiota structure by increasing the levels of the Akkermansia genus and decreasing the populations of the Desulfovibrio genus in CNAG mice. The alteration of gut microbiota was associated with gut bacteria BA metabolism. In addition, QZWT reduced BAs and especially decreased conjugated BAs in CNAG mice. Spearman's correlation analysis further confirmed the links between the changes in the gut microbiota and CNAG indices. Conclusions: QZWT can effectively inhibited gastrointestinal inflammatory responses of CNAG symptoms in mice; these effects may be closely related to restoring the balance of the gut microbiota and regulating BA metabolism to protect the gastric mucosa. This study provides a scientific reference for the pathogenesis of CNAG and the mechanism of QZWT treatment.
引用
收藏
页数:16
相关论文
共 17 条
  • [1] Bile acid metabolism involved into the therapeutic action of Xiaojianzhong Tang via gut microbiota to treat chronic atrophic gastritis in rats
    Liu, Yuetao
    Lian, Xu
    Qin, Xuemei
    PHYTOMEDICINE, 2023, 109
  • [2] Polysaccharide from Caulerpa lentillifera alleviates hyperlipidaemia through altering bile acid metabolism mediated by gut microbiota
    Long, Hairong
    Huang, Rui
    Zhu, Shuangjie
    Wang, Zuhan
    Liu, Xiaoling
    Zhu, Zhenjun
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 306
  • [3] The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial
    Xiao-xin Zhang
    Wei-wei Chen
    Bin She
    Rui-jie Luo
    Na Shi
    Ping Xue
    Xiao-nan Yang
    Qing Xia
    Trials, 15
  • [4] The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial
    Zhang, Xiao-xin
    Chen, Wei-wei
    She, Bin
    Luo, Rui-jie
    Shi, Na
    Xue, Ping
    Yang, Xiao-nan
    Xia, Qing
    TRIALS, 2014, 15
  • [5] Lactobacillus reuteri J1 prevents obesity by altering the gut microbiota and regulating bile acid metabolism in obese mice
    Zhang, Chenxi
    Fang, Ruxue
    Lu, Xingru
    Zhang, Yu
    Yang, Mo
    Su, Yue
    Jiang, Yujun
    Man, Chaoxin
    FOOD & FUNCTION, 2022, 13 (12) : 6688 - 6701
  • [6] Heptadecanoic acid and pentadecanoic acid crosstalk with fecal-derived gut microbiota are potential non-invasive biomarkers for chronic atrophic gastritis
    Gai, Xiao
    Qian, Peng
    Guo, Benqiong
    Zheng, Yixin
    Fu, Zhihao
    Yang, Decai
    Zhu, Chunmei
    Cao, Yang
    Niu, Jingbin
    Ling, Jianghong
    Zhao, Jin
    Shi, Hailian
    Liu, Guoping
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 12
  • [7] Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice
    Kasai, Kaichi
    Igarashi, Naoya
    Tada, Yuki
    Kani, Koudai
    Takano, Shun
    Yanagibashi, Tsutomu
    Usui-Kawanishi, Fumitake
    Fujisaka, Shiho
    Watanabe, Shiro
    Ichimura-Shimizu, Mayuko
    Takatsu, Kiyoshi
    Tobe, Kazuyuki
    Tsuneyama, Koichi
    Furusawa, Yukihiro
    Nagai, Yoshinori
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [8] Xiaohuafuning tang intervenes liver-depression-and-spleen-deficiency syndrome chronic-atrophic-gastritis by reshaping amino acid metabolism through gut Microbiota
    Chen, Li
    Xu, Shaoyu
    Wang, Sheng
    Chen, Hao
    Han, Yanquan
    PHYTOMEDICINE, 2025, 136
  • [9] Chaihu-shugan-san alleviates depression-like behavior in mice exposed to chronic unpredictable stress by altering the gut microbiota and levels of the bile acids hyocholic acid and 7-ketoDCA
    Ma, Chong
    Yuan, Dun
    Renaud, Stephen James
    Zhou, Ting
    Yang, Fan
    Liou, Yuligh
    Qiu, Xinjian
    Zhou, Lu
    Guo, Ying
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice
    Hu, Weiting
    Gong, Wenyu
    Yang, Fan
    Cheng, Rui
    Zhang, Gerong
    Gan, Lu
    Zhu, Yikun
    Qin, Weiwei
    Gao, Ying
    Li, Xing
    Liu, Jing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 147